Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC [Phase 3]
A Phase 3 trial comparing TPF induction chemotherapy versus PF adjuvant chemotherapy with concurrent chemoradiotherapy for locally advanced …
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal Carcinoma
A clinical trial update reports that hemoglobin, neutrophil-to-lymphocyte ratio, and platelet count may improve prognosis prediction in pati…
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial evaluating induction gemcitabine and cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma [Phase 1]
This Phase 1 trial update evaluated concurrent chemoradiotherapy with famitinib in patients with locally advanced nasopharyngeal carcinoma; …
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma [Phase 1, Phase 2]
A safety and efficacy study evaluating icotinib in combination with intensity-modulated radiotherapy for nasopharyngeal carcinoma (Phase 1/P…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Dose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical Trial [Phase 1]
Phase I dose-escalation study of lobaplatin given concurrently with IMRT for nasopharyngeal carcinoma, evaluating safety and preliminary tum…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Capecitabine For Nasopharyngeal Cancer [Phase 2]
Phase 2 clinical trial of capecitabine for nasopharyngeal carcinoma has completed, with Dana-Farber Cancer Institute listed as sponsor.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients [Phase 2]
A Phase 2 clinical trial tested whether oral supplements improve nutritional status in locally advanced nasopharyngeal carcinoma patients; t…
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating induction cisplatin and capecitabine followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma has compl…
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating early and whole-course nutritional support with Nutren Optimum during IMRT for nasopharyngeal carcinom…
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC [Phase 2]
Phase II trial evaluating chemotherapy with or without Endostar continuous IV infusion in refractory nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis [Phase 2]
A Phase 2 trial evaluating atorvastatin to prevent carotid stenosis in nasopharyngeal carcinoma patients receiving radiotherapy has been sus…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy [NA]
A clinical trial update comparing oxycodone to control for chemoradiotherapy-induced oral mucositis pain in nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients [Phase 2]
A Phase 2 clinical trial update reports that aspirin may improve survival in patients with advanced nasopharyngeal carcinoma (N2-3).
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA
This completed clinical trial reports long-term treatment outcomes for stage III nasopharyngeal carcinoma patients and evaluates risk groupi…
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: NBI to Detect Post-RT Mucosal Residual NPC [NA]
The trial evaluated using narrow-band imaging (NBI) to detect residual mucosal disease after radiotherapy in nasopharyngeal carcinoma, with …
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes [Phase 2]
Phase 2 study evaluating carboplatin and docetaxel followed by Epstein-Barr virus–specific cytotoxic T lymphocytes in nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) [Phase 2]
A Phase 2 clinical trial evaluating induction chemotherapy with docetaxel, cisplatin, and fluorouracil with intensity-modulated radiotherapy…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) [Phase 2]
A Phase 2 trial update is reported for apatinib in treating recurrent or metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC. [Phase 2]
Phase 2 clinical trial evaluating the combination of lobaplatin and 5-fluorouracil for recurrent nasopharyngeal carcinoma; current study sta…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial update reports on eliminating adjuvant chemotherapy for selected stage II and III nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Nasopharyngeal Carcinoma (NPC) Axitinib [Phase 2]
Phase 2 trial of axitinib in recurrent or metastatic nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma [Phase 1]
Phase 1 clinical trial evaluating Epstein-Barr Virus-Specific Immunotherapy for nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 clinical trial compares IMRT plus cisplatin versus IMRT alone in stage II nasopharyngeal carcinoma; current status is not disclose…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]
This document provides an update on a Phase 2 trial evaluating concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carci…